Drugs, devices, biologics — unified by a canonical entity graph no global competitor owns. Four products on one schema. Zero translation layers.
One canonical layer. Four products. Defensible by architecture.
A workflow application for hospital procurement. Three regulatory intelligence rails for global pharma. Unified by a shared canonical identity layer.
AI procurement operating system for hospitals. Tender to PO in 48 hours. NABH compliance mode. Explainable AI bid scoring.
Visit oushvaa.ai →Canonical drug catalogue with salt-level deduplication, regulatory cross-reference, and pricing-violation tracking.
Visit drugiq.ai →Adverse event records, canonical devices across regulators, manufacturers with parent-child cross-country relationships.
Visit medeviq.ai →Editorial-tier biologics across modalities. Multi-regulator coverage. FDA establishment-level CDMO supply chain.
Visit biologicsiq.ai →One company, drug, device, or biologic resolves to a single canonical identifier across every product on the platform. No translation tables. No fuzzy joins. Built on one schema from day one.
FDA, EMA, MHRA, PMDA, Health Canada, TGA, Swissmedic, ANVISA, EUDAMED — and thirty-five more sit in the schema, lit up as customer entitlements call them. Pay for the markets you actually need.
Premium intelligence stays premium. No anonymous public surfaces, no free-tier API exposure. Verified academic access opens in 2027 via institutional verification — not open web scraping.